Qilian Competitors

Stocks . USA . 
Stock . Qilian International Holding
BGM Stock   1.22  0.26  17.57%   
Qilian International competes with ANI Pharmaceuticals, Phibro Animal, Twist Bioscience, Avadel Pharmaceuticals, and Procept Biorobotics; as well as few others. The company runs under Pharmaceuticals sector within Health Care industry. Analyzing Qilian International competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Qilian International to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Qilian International Correlation with its peers.

Qilian International vs Structure Therapeutics Correlation

Pay attention - limited upside

The correlation between Qilian International Holding and GPCR is -0.8 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Qilian International Holding and GPCR in the same portfolio, assuming nothing else is changed.

Moving together with Qilian Stock

  0.63VLCN Volcon Inc Symbol ChangePairCorr

Moving against Qilian Stock

  0.87AMKBY AP Moeller MaerskPairCorr
  0.87RBGPF Reckitt BenckiserPairCorr
  0.63BA BoeingPairCorr
  0.54AA Alcoa CorpPairCorr
  0.52LPCN LipocinePairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.050.927.57
Details
Intrinsic
Valuation
LowRealHigh
0.061.197.84
Details
Naive
Forecast
LowNextHigh
0.010.467.11
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.314.698.08
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Qilian International. Your research has to be compared to or analyzed against Qilian International's peers to derive any actionable benefits. When done correctly, Qilian International's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Qilian International.

Qilian International Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Qilian International and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Qilian and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Qilian International does not affect the price movement of the other competitor.

High positive correlations

GPCR
+ 0.82
TWST
EWTX
+ 0.79
TWST
QDEL
+ 0.75
MESO
GPCR
+ 0.74
EWTX
CLOV
+ 0.7
PRCT
GPCR
+ 0.64
QDEL
  

High negative correlations

MESO
- 0.74
PAHC
AVDL
- 0.57
ANIP
QDEL
- 0.51
PAHC
GPCR
- 0.43
PAHC
MESO
- 0.39
ANIP
PRCT
- 0.37
PAHC

Risk-Adjusted Indicators

There is a big difference between Qilian Stock performing well and Qilian International Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Qilian International's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANIP  1.46 (0.17) 0.00 (0.41) 0.00 
 0.00 
 2.77 
(2.78)
 13.39 
PAHC  2.21  0.30  0.09 (0.48) 2.50 
(2.60)
 4.15 
(4.49)
 12.56 
TWST  3.03  0.71  0.23  0.31  2.83 
(3.72)
 7.70 
(4.95)
 16.27 
AVDL  0.84  0.28  0.16 (0.73) 0.88 
(1.05)
 0.70 
(0.48)
 29.13 
PRCT  2.63 (0.26) 0.00 (0.10) 0.00 
 0.00 
 7.06 
(5.10)
 18.49 
MESO  2.65  0.14  0.05  0.11  3.30 
(2.83)
 5.49 
(4.87)
 19.08 
CLOV  2.41 (0.46) 0.00 (0.24) 0.00 
 0.00 
 5.26 
(4.86)
 17.39 
QDEL  2.91  0.55  0.16  0.26  3.25 
(3.31)
 8.12 
(4.88)
 24.38 
EWTX  4.25  0.91  0.19  0.84  4.44 
(5.25)
 12.91 
(5.57)
 38.85 
GPCR  5.28  1.96  0.42 (2.19) 3.57 
(6.87)
 8.23 
(7.09)
 115.10 

Qilian International Competitive Analysis

The better you understand Qilian International competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Qilian International's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Qilian International's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BGM ANIP PAHC TWST AVDL PRCT MESO CLOV QDEL EWTX
 17.57 
 1.22 
Qilian
 0.28 
 81.50 
ANI
 21.95 
 50.00 
Phibro
 2.12 
 47.10 
Twist
 0.05 
 21.57 
Avadel
 5.29 
 27.40 
Procept
 5.36 
 16.08 
Mesoblast
 3.32 
 2.04 
Clover
 2.12 
 28.69 
Quidel
 4.50 
 27.19 
Edgewise
Market Volatility
(90 Days Market Risk)
Extremely Dangerous
Very steady
Very steady
Very steady
Not too volatile
Not too volatile
Not too volatile
Unstable
Not too volatile
Not too volatile
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Good
Fair
Weakest
Fair
Weakest
Good
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Small
Tiny
Low
Small
Low
Low
Risky
Small
Moderate
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Sell
Strong Buy
Sell
Sell
Cautious Hold
Sell
Strong Sell
Cautious Hold
Current Ratio
N/A
3.35
2.97
6.58
2.72
16.01
1.9
1.29
1.66
27.49
Net Asset
53 M
1.28 B
1.36 B
641.86 M
164.24 M
534.02 M
784.68 M
580.74 M
6.42 B
486.82 M
Profit Margin
-0.26
0.0491
0.0484
-0.2
-0.0011
-0.28
N/A
-0.0329
-0.43
N/A
EBITDA
(2.37 M)
63.12 M
146.85 M
(52.1 M)
(35.57 M)
(82 M)
(73.66 M)
(44.94 M)
(1.49 B)
(156.54 M)
Operating Margin
-0.0541
0.1
0.13
-0.32
0.025
-0.28
-3.02
-0.0491
0.0667
N/A
Current Valuation
577.07 M
2.14 B
2.4 B
2.77 B
2.03 B
1.41 B
2.18 B
807.31 M
4.62 B
2.5 B
Price To Book
2.64
3.55
5.37
6.29
21.58
4.29
3.71
3.26
0.93
5.62
Retained Earnings
4.35 M
(100.28 M)
272.7 M
(1.32 B)
(794.33 M)
(545.99 M)
(1.01 B)
(2.2 B)
135.8 M
(378.58 M)
Current Asset
N/A
192.58 M
342.83 M
N/A
177.85 M
N/A
88.82 M
N/A
240.66 M
N/A
Five Year Return
N/A
N/A
1.85
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
1.46
0.5
0.8
2.27
1.63
0.99
0.76
2.15
0.72
0.28
Number Of Employees
298
897
2.48 K
979
188
756
81
570
6.6 K
136
Shares Outstanding
180.62 M
22.46 M
20.45 M
61.27 M
98.15 M
55.88 M
128.29 M
424.3 M
67.93 M
105.87 M
Cash Flow From Operations
N/A
64.02 M
80.12 M
(47.63 M)
(46.91 M)
(99.21 M)
(49.95 M)
34.84 M
83 M
(109.03 M)
Annual Yield
N/A
N/A
0.0116
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
8.91 M
624.09 M
761.55 M
137.32 M
1.7 M
80.25 M
128.16 M
239.6 M
2.68 B
4.74 M
Return On Equity
-0.17
0.0866
0.24
-0.17
-0.0032
-0.27
-0.19
-0.17
-0.45
-0.3
Return On Asset
-0.0384
0.0237
0.0855
-0.13
-0.0034
-0.13
-0.0537
-0.0594
0.0142
-0.21
Number Of Shares Shorted
70.46 K
2.94 M
1.07 M
12.5 M
3.61 M
6.58 M
2.64 M
40.19 M
10.52 M
9.42 M
Book Value Per Share
1.85
24.19
7.69
7.47
1.01
6.81
0.47
0.66
29.99
5.28
Current Liabilities
N/A
11.76 M
108.78 M
N/A
59.19 M
N/A
29.41 M
N/A
30.83 M
N/A
Total Asset
53 M
1.28 B
1.36 B
641.86 M
164.24 M
534.02 M
784.68 M
580.74 M
6.42 B
486.82 M
Short Ratio
0.17
5.52
4.44
10.14
2.25
6.08
10.06
8.13
12.82
5.04
Debt To Equity
N/A
0.86
1.79
0.12
2.63
0.23
0.21
0.066
0.6
0.007
Target Price
N/A
110.38
43.0
49.89
20.94
50.73
35.0
3.23
38.33
38.17
Last Dividend Paid
N/A
N/A
0.48
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
96.51
98.06
98.5
96.62
95.59
2.53
32.18
99.06
99.55
Market Capitalization
479.49 M
1.83 B
1.66 B
2.84 B
2.12 B
1.63 B
1.94 B
1.09 B
1.9 B
3.14 B
Price To Earning
N/A
43.35
11.39
N/A
61.46
N/A
-5.9
N/A
5.56
3.45
Price To Earnings To Growth
N/A
1.06
1.66
-0.04
0.07
-0.47
N/A
-0.08
7.19
N/A
Price To Sales
16.05
2.21
1.19
7.25
8.52
5.44
133.78
0.61
0.7
N/A
Net Income
N/A
(18.52 M)
48.26 M
(77.67 M)
(48.83 M)
(91.41 M)
(102.14 M)
(43.01 M)
(2.05 B)
(133.81 M)
Earnings Per Share
-0.29
1.6
1.66
-1.27
N/A
-1.53
-0.85
-0.11
-17.41
-1.57
Shares Owned By Insiders
7.28
9.99
0.6
1.5
1.05
4.41
5.0
3.33
0.94
0.45
Revenue
29.87 M
614.38 M
1.3 B
376.57 M
169.12 M
224.5 M
17.2 M
1.37 B
2.78 B
N/A
Working Capital
20.99 M
334 M
517.13 M
241.56 M
85.37 M
428.71 M
101.72 M
129.61 M
220.1 M
451.62 M
Cash And Equivalents
N/A
63.38 M
98.67 M
504.97 M
104.12 M
269.81 M
85.5 M
711.78 M
264 M
248.4 M
Cash Per Share
N/A
3.89
2.44
8.93
1.74
6.05
0.62
1.49
4.0
4.99
Gross Profit
870.77 K
502.34 M
443.03 M
202.13 M
235.88 M
193.58 M
(22.74 M)
375.61 M
1.28 B
N/A
Day Typical Price
1.28
82.17
47.74
47.01
21.59
28.06
16.24
2.06
29.03
27.95
Accumulation Distribution
208958.0
11138.39
134974.0
105192.0
0.0023
118132.0
11026.29
227815.0
61395.21
74762.53
Market Facilitation Index
0.0
0.0
0.0
0.0
0.05
0.0
0.0
N/A
0.0
0.0
Daily Balance Of Power
(0.37)
0.0888
1.30814
(0.44)
(0.20)
(0.66)
(1.44)
(1.00)
(0.40)
(0.48)
Period Momentum Indicator
(0.26)
0.23
9.0
(1.02)
(0.01)
(1.53)
(0.91)
(0.07)
(0.62)
(1.28)
Rate Of Daily Change
0.82
1.0
1.22
0.98
1.0
0.95
0.95
0.97
0.98
0.96
Day Median Price
1.31
82.51
46.61
46.96
21.6
28.4
16.33
2.07
29.2
28.33
Price Action Indicator
(0.22)
(0.89)
7.89
(0.37)
(0.03)
(1.76)
(0.70)
(0.06)
(0.81)
(1.77)
Coefficient Of Variation
(235.35)
(1,496)
1300.18
503.21
1095.03
(1,934)
1590.48
(816.09)
633.0
684.9
Mean Deviation
3.83
1.46
2.21
3.03
0.8422
2.63
2.65
2.41
2.91
4.25
Jensen Alpha
(2.91)
(0.17)
0.2978
0.7065
0.281
(0.26)
0.1366
(0.46)
0.5504
0.9095
Total Risk Alpha
(3.14)
(0.26)
0.1032
0.6077
0.126
(0.37)
0.0455
(0.55)
0.4447
0.6428
Sortino Ratio
N/A
N/A
0.0905
0.229
0.1628
N/A
0.05
N/A
0.1604
0.1885
Downside Variance
N/A
N/A
7.19
11.07
2.05
N/A
11.54
N/A
14.01
23.51
Standard Deviation
6.65
2.2
3.74
4.06
3.05
3.62
3.42
3.19
4.08
6.57
Kurtosis
13.4
8.79
18.47
1.52
49.15
1.77
1.17
1.78
2.17
4.56
Potential Upside
4.59
2.77
4.15
7.7
0.6975
7.06
5.49
5.26
8.12
12.91
Treynor Ratio
(1.35)
(0.41)
(0.48)
0.3082
(0.73)
(0.10)
0.1052
(0.24)
0.2624
0.8373
Maximum Drawdown
30.2
13.39
12.56
16.27
29.13
18.49
19.08
17.39
24.38
38.85
Variance
44.17
4.84
13.99
16.5
9.27
13.09
11.69
10.17
16.68
43.17
Market Risk Adjusted Performance
(1.34)
(0.40)
(0.47)
0.3182
(0.72)
(0.09)
0.1152
(0.23)
0.2724
0.8473
Risk Adjusted Performance
(0.31)
(0.04)
0.0658
0.1575
0.0762
(0.03)
0.0551
(0.08)
0.1269
0.1186
Skewness
(2.76)
1.71
3.04
0.4598
6.44
1.15
(0.15)
0.8277
0.5509
1.25
Semi Deviation
N/A
N/A
2.5
2.83
0.8753
N/A
3.3
N/A
3.25
4.44
Information Ratio
(0.43)
(0.09)
0.0649
0.1876
0.0765
(0.06)
0.0497
(0.14)
0.1469
0.1391
Value At Risk
(12.97)
(2.78)
(4.49)
(4.95)
(0.48)
(5.10)
(4.87)
(4.86)
(4.88)
(5.57)
Expected Short fall
N/A
N/A
(2.60)
(3.72)
(1.05)
N/A
(2.83)
N/A
(3.31)
(5.25)
Downside Deviation
N/A
N/A
2.68
3.33
1.43
N/A
3.4
N/A
3.74
4.85
Semi Variance
N/A
N/A
6.24
7.98
0.7662
N/A
10.92
N/A
10.55
19.72

Qilian International Competition Performance Charts

Five steps to successful analysis of Qilian International Competition

Qilian International's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Qilian International in relation to its competition. Qilian International's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Qilian International in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Qilian International's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Qilian International, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Qilian International position

In addition to having Qilian International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sport Products Thematic Idea Now

Sport Products
Sport Products Theme
Companies manufacturing sporting goods and accessories. The Sport Products theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Qilian International is a strong investment it is important to analyze Qilian International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Qilian International's future performance. For an informed investment choice regarding Qilian Stock, refer to the following important reports:
How To Invest In Qilian
Details
Is Qilian Stock a good investment?
Details
What is Qilian International's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Qilian International Correlation with its peers.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Pharmaceuticals sector continue expanding? Could Qilian diversify its offerings? Factors like these will boost the valuation of Qilian International. Projected growth potential of Qilian fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Qilian International data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Qilian International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Qilian International's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Qilian International's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between Qilian International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Qilian International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Qilian International's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY